These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 1813003)

  • 1. Gonadotropin-releasing hormone agonists: emerging modification of treatment regimens.
    Hodgen GD
    Curr Opin Obstet Gynecol; 1991 Jun; 3(3):352-7. PubMed ID: 1813003
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical applications of gonadotropin-releasing hormones in reproductive disorders.
    Moghissi KS
    Endocrinol Metab Clin North Am; 1992 Mar; 21(1):125-40. PubMed ID: 1576979
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Therapeutic uses of gonadotropin-releasing hormone analogs.
    Andreyko JL; Marshall LA; Dumesic DA; Jaffe RB
    Obstet Gynecol Surv; 1987 Jan; 42(1):1-21. PubMed ID: 3543765
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Gonadotropin-releasing hormone analogs].
    Krysiak R; Okopień B; Herman ZS
    Pol Merkur Lekarski; 2005 May; 18(107):585-9. PubMed ID: 16161962
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Pharmacology and possibilities for use of gonadotropin releasing hormone analogs].
    Breckwoldt M; Zahradnik HP; Karck U
    Gynakologe; 1992 Aug; 25(4):241-6. PubMed ID: 1398253
    [No Abstract]   [Full Text] [Related]  

  • 6. The histrelin implant: a novel treatment for central precocious puberty.
    Hirsch HJ; Gillis D; Strich D; Chertin B; Farkas A; Lindenberg T; Gelber H; Spitz IM
    Pediatrics; 2005 Dec; 116(6):e798-802. PubMed ID: 16322137
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combined use of growth hormone and gonadotropin-releasing hormone analogues: the national cooperative growth study experience.
    Kohn B; Julius JR; Blethen SL
    Pediatrics; 1999 Oct; 104(4 Pt 2):1014-8. PubMed ID: 10506254
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An evidence-based approach to hormonal therapies for premenopausal women with fibroids.
    Lethaby AE; Vollenhoven BJ
    Best Pract Res Clin Obstet Gynaecol; 2008 Apr; 22(2):307-31. PubMed ID: 17905660
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gonadotropin-releasing hormone agonist and add-back therapy: what do the data show?
    Surrey ES
    Curr Opin Obstet Gynecol; 2010 Aug; 22(4):283-8. PubMed ID: 20498596
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacologic management of endometriosis.
    Saltiel E; Garabedian-Ruffalo SM
    Clin Pharm; 1991 Jul; 10(7):518-31. PubMed ID: 1830521
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gonadotropin-releasing hormone agonists. Current uses for these increasingly important drugs.
    Winkel CA
    Postgrad Med; 1994 May; 95(6):111-8. PubMed ID: 8170869
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Growth hormone and GnRHa combination therapy in the management of precocious puberty.
    Khadilkar VV; Khadilkar VV; Maskati GB
    Indian Pediatr; 2005 Jan; 42(1):57-60. PubMed ID: 15695861
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reduction of vasomotor symptoms and bone mineral density loss with combined norethindrone and long-acting gonadotropin-releasing hormone agonist therapy of symptomatic endometriosis: a prospective randomized trial.
    Surrey ES; Judd HL
    J Clin Endocrinol Metab; 1992 Aug; 75(2):558-63. PubMed ID: 1386374
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term GnRH agonist treatment for female central precocious puberty does not impair reproductive function.
    Heger S; Müller M; Ranke M; Schwarz HP; Waldhauser F; Partsch CJ; Sippell WG
    Mol Cell Endocrinol; 2006 Jul; 254-255():217-20. PubMed ID: 16757104
    [TBL] [Abstract][Full Text] [Related]  

  • 15. New approaches to the management of fibroids.
    Shaw RW
    Curr Opin Obstet Gynecol; 1991 Dec; 3(6):859-64. PubMed ID: 1818725
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Use of GnGH (GnRH-A) in gynecology].
    Ciardo A; Spina V; Aleandri V
    Minerva Ginecol; 1998; 50(1-2):25-9. PubMed ID: 9577152
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of endometriosis with a long-acting gonadotropin-releasing hormone agonist plus medroxyprogesterone acetate.
    Cedars MI; Lu JK; Meldrum DR; Judd HL
    Obstet Gynecol; 1990 Apr; 75(4):641-5. PubMed ID: 2138265
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Bone loss induced by GnRHa treatment in women].
    Matsuo H
    Nihon Rinsho; 2003 Feb; 61(2):314-8. PubMed ID: 12638227
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The GnRH agonists in the treatment of uterine leiomyomas.
    Bianchi S; Fedele L
    Acta Eur Fertil; 1989; 20(1):5-10. PubMed ID: 2675524
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy of long-term, low-dose gonadotropin-releasing hormone agonist therapy (draw-back therapy) for adenomyosis.
    Akira S; Mine K; Kuwabara Y; Takeshita T
    Med Sci Monit; 2009 Jan; 15(1):CR1-4. PubMed ID: 19114964
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.